Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Asset Writedowns and Impairment (2016 - 2024)

Bruker (BRKR) has disclosed Asset Writedowns and Impairment for 12 consecutive years, with $38.6 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment rose 38700.0% year-over-year to $38.6 million, compared with a TTM value of $60.2 million through Dec 2024, up 210.31%, and an annual FY2025 reading of $76.0 million, up 26.25% over the prior year.
  • Asset Writedowns and Impairment was $38.6 million for Q4 2024 at Bruker, up from $20.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $38.6 million in Q4 2024 and bottomed at -$1.9 million in Q3 2022.
  • Average Asset Writedowns and Impairment over 3 years is $7.4 million, with a median of $1.6 million recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment tumbled 106.25% in 2023, then skyrocketed 38700.0% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $1.6 million in 2022, then crashed by 106.25% to -$100000.0 in 2023, then surged by 38700.0% to $38.6 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for BRKR at $38.6 million in Q4 2024, $20.2 million in Q2 2024, and $1.4 million in Q1 2024.